MilliporeSigma, profile picture

MilliporeSigma

208 Slideshow
Sort by
Launch of our new Titanium Dioxide Alternative
byMilliporeSigma
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Surface Plasmon Resonance
byMilliporeSigma
 
The Future of Pharma- and Biopharmaceutical Audits
byMilliporeSigma
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Landscape
byMilliporeSigma
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
byMilliporeSigma
 
Latest advancements of melt based 3D printing technologies for oral drug delivery
byMilliporeSigma
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes and Other Key Steps
byMilliporeSigma
 
How does the ICH Q5A revision impact viral safety strategies for biologics?
byMilliporeSigma
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems Agnostic Orchestration
byMilliporeSigma
 
Insights from a Global Collaboration Accelerating Vaccine Development with an Optimized VLP Platform
byMilliporeSigma
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
byMilliporeSigma
 
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot Release
byMilliporeSigma
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patient's Taste Test
byMilliporeSigma
 
How to Accelerate and Enhance ADC Therapies
byMilliporeSigma
 
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Systems
byMilliporeSigma